Prioritizing global strategies to cure MS
A Cobo-Calvo, M Tintore - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Multiple Sclerosis Journal 00 (0) 2 journals. sagepub. com/home/msj exclude contributions
from the pharmaceutical and biotech sectors, playing a significant role in MS research and …
from the pharmaceutical and biotech sectors, playing a significant role in MS research and …
Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies
VM Leavitt, JD Dworkin, R Galioto, AS Ratzan - Multiple Sclerosis and …, 2024 - Elsevier
Background Current treatment guidelines recommend consideration of disease-modifying
therapy (DMT) for all multiple sclerosis (MS) patients, but barriers to access have begun to …
therapy (DMT) for all multiple sclerosis (MS) patients, but barriers to access have begun to …